RightBio Metrics

---

PROBLEM:

Published studies cite that 21-56% of tubes intended for the stomach are confirmed elsewhere in the body.*

• US Nursing and Patient Safety Organizations have issued warnings to stop using auscultation and recommend the use of pH to confirm gastric placement**
• United Kingdom and most developed countries use pH first line to confirm NG/OG tube gastric placement and only use x-ray if pH is not conclusive.***
• In 2018 the US ASPEN will endorse and publish a Clinical Practice Statement that says to use pH first line and only use x-ray if pH is not conclusive.

NPSA Patient Safety Alert (March 2011)***

Higher rates of misplacement with x-ray

The ONLY FDA cleared, CE Marked, CLIA waived product that uses pH to confirm gastric acidity for tubes intended to end in the stomach.

• immediate results
• no x-ray/radiation exposure
• no daily QC requirements, no exposure to gastric fluids, accurate

Reimbursement: CPT Code 83986QW

Some think of using our pH indicators as an insurance policy to improve the safety of placing tubes with little to no added cost to the hospital. If your hospital is reimbursed for bedside glucose testing you may be able to get reimbursement for the RightSpotpH®
 

Single-use only. Latex free

*The Journal of Perinatal & Neonatal Nursing (2015) Following the Evidence. Enteral Tube Placement and Verification in Neonates and Young Children. Clifford, Patricia; Heimall, Lauren; Brittingham, Lori; Finn Davis, Katherine; Neonatal Intensive Care (2015) Validation Study of the RightSpot Infant pH Indicator for Verification of Feeding Tube Placement in the Neonatal Intensive Care Unit. Martin, Gregory C.; Wade, Christine.

**ENA Clinical Practice Guideline (2015); AACN Practice Alerts (2005 & 2016); CHABlind Pediatric NG Tube Placement Patient Safety Alert (2012)***NPSA Patient Safety Alert, NHS (March 2011)
 

 PROBLEM:

• Published studies cite that 21-56% of tubes intended for the stomach are confirmed elsewhere in the body.*
• Nursing and Patient Safety Organizations are calling for the immediate discontinuation of auscultation to confirm tube gastric placement and use of pH as one of the indicators.**
• NICU babies are the most vulnerable, yet most US hospitals still use auscultation to confirm gastric placement. Studies show that NICU babies stomachs are acidified and it is possible to obtain aspirate.***
• The United Kingdome uses pH first line for their NICU population.****

The ONLY FDA cleared, CE Marked, CLIA waived product that uses pH to confirm gastric acidity for tubes intended to end in the stomach

RightBio Metrics pH indicators are a cost-effective way to confirm gastric acidity of tubes intended for the stomach. Published studies show pH can be used in place of x-ray to confirm initial placement. In some hospitals x-ray is only used when pH is inconclusive.**

Additionally, the pH indicators can be used:

• when there is a suspected mis-placement
• when there is a shift change
• prior to each feed/medication delivery.

Reimbursement: CPT Code 83986QW

Some think of using our pH indicators as an insurance policy to improve the safety of placing tubes with little to no added cost to the hospital. If your hospital is reimbursed for bedside glucose testing you may be able to get reimbursement for the RightSpot pH® SmallBore

Single use only. Latex free

*The Journal of Perinatal & Neonatal Nursing (2015) Following the Evidence. Enteral Tube Placement and Verification in Neonates and Young Children. Clifford, Patricia; Heimall, Lauren; Brittingham, Lori; Finn Davis, Katherine;

**ENA Clinical Practice Guideline (2015); AACN Practice Alerts (2005 & 2016); CHABlind Pediatric NG Tube Placement Patient Safety Alert (2012)

***Neonatal Intensive Care (2015) Validation Study of the RightSpot Infant pH Indicator for Verification of Feeding Tube Placement in the Neonatal Intensive Care Unit. Martin, Gregory C.; Wade, Christine.

NHS Alert on Neonates, Reducing the harm caused by gastric feeding tubes under the care of neonatal units, (2005)

****NPSA Patient Safety Alert, NHS (March 2011)